Drug class
Meningococcal Vaccines - Serogroups A,C,Y,W135 represents a therapeutic biological class of quadrivalent vaccines formulated to provide active immunization against invasive disease caused by *Neisseria meningitidis* serogroups A, C, Y, and W-135. Read more about Meningococcal Vaccines - Serogroups A,C,Y,W135
16 drugs in this class 4 manufacturers
Meningococcal Vaccines - Serogroups A,C,Y,W135 represents a therapeutic biological class of quadrivalent vaccines formulated to provide active immunization against invasive disease caused by *Neisseria meningitidis* serogroups A, C, Y, and W-135.
These formulations primarily consist of capsular polysaccharides chemically conjugated to immunogenic carrier proteins—such as diphtheria toxoid, CRM197, or tetanus toxoid—to induce T-cell–dependent immunity, higher antibody titers, and long-term immunological memory.
Clinically, these vaccines are indicated to prevent life-threatening invasive meningococcal conditions, most notably acute bacterial meningitis and meningococcemia, across pediatric, adolescent, and high-risk adult populations.
Meningococcal Vaccines - Serogroups A,C,Y,W135 represents a therapeutic biological class of quadrivalent vaccines formulated to provide active immunization against invasive disease caused by *Neisseria meningitidis* serogroups A, C, Y, and W-135 These formulations primarily consist of capsular polysaccharides chemically conjugated to immunogenic carrier proteins—such as diphtheria toxoid, CRM197, or tetanus toxoid—to induce T-cell–dependent immunity, higher antibody titers, and long-term immunol...
Meningococcal Vaccines - Serogroups A,C,Y,W135 represents a therapeutic biological class of quadrivalent vaccines formulated to provide active immunization against invasive disease caused by *Neisseria meningitidis* serogroups A, C, Y, and W-135 These formulations primarily consist of capsular polysaccharides chemically conjugated to immunogenic carrier proteins—such as diphtheria toxoid, CRM197, or tetanus toxoid—to induce T-cell–dependent immunity, higher antibody titers, and long-term immunol...
These formulations primarily consist of capsular polysaccharides chemically conjugated to immunogenic carrier proteins—such as diphtheria toxoid, CRM197, or tetanus toxoid—to induce T-cell–dependent immunity, higher antibody titers, and long-term immunological memory
Clinically, these vaccines are indicated to prevent life-threatening invasive meningococcal conditions, most notably acute bacterial meningitis and meningococcemia, across pediatric, adolescent, and high-risk adult populations
Clinically, these vaccines are indicated to prevent life-threatening invasive meningococcal conditions, most notably acute bacterial meningitis and meningococcemia, across pediatric, adolescent, and high-risk adult populations
Following a drug class requires a free Physicians Office Resource account.
